Synthelis

Synthelis

Synthelis

SYNTHELIS is specialized in membrane protein production for #drug discovery, #vaccine, protein therapy & structural biology, using a cell-free expression system
Raised
$784.8k
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$784,826
Venture capital - 2014
Team Size
2
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Synthelis makes some noise.